Relx (RELX) Set to Announce Earnings on Thursday

Share on StockTwits

Relx (NYSE:RELX) is scheduled to post its quarterly earnings results on Thursday, July 25th.

Shares of NYSE:RELX opened at $24.37 on Tuesday. The company has a current ratio of 0.44, a quick ratio of 0.40 and a debt-to-equity ratio of 2.11. The stock has a fifty day moving average of $24.35. The company has a market capitalization of $25.67 billion, a price-to-earnings ratio of 21.57, a PEG ratio of 3.50 and a beta of 0.48. Relx has a 12-month low of $19.23 and a 12-month high of $24.99.

Separately, Zacks Investment Research lowered shares of HENGAN INTL GRP/ADR from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, May 21st.

Relx Company Profile

RELX PLC provides information based-analytics and decision tools for professional and business customers in the United States and internationally. It operates through four segments: Scientific, Technical & Medical; Risk & Business Analytics; and Exhibitions. The Scientific, Technical & Medical segment provides information and analytics to institutions and professionals that enables progress in science, advance healthcare, and performance improvement.

See Also: Why do companies pay special dividends?

Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Insider Selling: Fluidigm Co.  Insider Sells $19,955.25 in Stock
Insider Selling: Fluidigm Co. Insider Sells $19,955.25 in Stock
Insider Buying: Palatin Technologies, Inc.  Director Buys $19,418.80 in Stock
Insider Buying: Palatin Technologies, Inc. Director Buys $19,418.80 in Stock
iShares Barclays 1-3 Year Treasry Bnd Fd  Shares Sold by Financial Gravity Wealth Inc.
iShares Barclays 1-3 Year Treasry Bnd Fd Shares Sold by Financial Gravity Wealth Inc.
Lakeland Financial Co.  CFO Acquires $22,400.00 in Stock
Lakeland Financial Co. CFO Acquires $22,400.00 in Stock
Insider Selling: The Ensign Group, Inc.  CFO Sells $21,610.80 in Stock
Insider Selling: The Ensign Group, Inc. CFO Sells $21,610.80 in Stock
Halozyme Therapeutics, Inc.  SVP Sells $22,177.60 in Stock
Halozyme Therapeutics, Inc. SVP Sells $22,177.60 in Stock


© 2006-2019 Ticker Report